
1. Technology overview
Sêmeia is a French digital health company founded in 2017 and based in Toulouse, France. It develops technology for the follow-up of patients with chronic diseases and supports care teams that need to track many patients outside the hospital.
Its platform MedicWise is a CE class IIa digital medical device for remote monitoring. It collects health data automatically, raises customized alerts for care teams and offers condition-specific modules for pulmonology, mental health, digestive, cardiac, kidney and liver diseases. A team of nurses trains patients and helps clinicians handle alerts.
2. Highlighted features & specifications
- Automated data collection: gathers patient health data without manual entry.
- Alerts and follow-up plans: sends customized alerts to care teams.
- Condition modules: PneumoWise, MentalWise, DigestWise, CardioWise, NephroWise and HepatoWise.
- Interoperability: exchanges data through FHIR, HL7 v2 and protected SFTP servers.
- Nurse support: nurses train patients and help clinicians with alerts.
- Deployment support: provides onboarding, training and a dedicated deployment manager.
3. Potential application
A provincial hospital could monitor kidney disease patients living far from the hospital. A cardiology department could follow heart patients after discharge. A hospital network could extend specialist follow-up to rural areas.
4. Benefits
In the company's reported nephrology results, hospitalizations fell 26 percent and physician time fell 73 percent. A lung transplant cohort showed 60 percent fewer rehospitalizations for infections. Automatic data collection removes manual entry, and FHIR and HL7 v2 interoperability fits existing hospital systems.
5. Market trends & opportunities
Remote monitoring of chronic patients is spreading as health systems seek to reduce hospital stays and reach patients in underserved areas. In Vietnam and Southeast Asia, growing chronic disease burdens and uneven access to specialists create demand for tele-monitoring tools.
6. Other information
Founded in 2017 in Toulouse, France, with about 70 employees. Raised 21 million EUR in May 2026 with Acton Capital, Mutuelles Impact and Citizen Capital, joined by Banque des Territoires and Orange Ventures. Acquired Optim'Care in 2022 and Healabs in 2025. MedicWise is a CE class IIa medical device.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































